Abu Dhabi, United Arab Emirates - Tuesday, 18. February 2025

VentureOne and ADASI Partner to Integrate Advanced Autonomous Flight Technologies Powered by TII – Perceptra and Saluki Unveiled at IDEX 2025

As dual-use technologies increasingly drive economies of scale worldwide, ADASI, a leader in UAV system manufacturing, has announced their adoption of two advanced autonomous flight technologies by Abu Dhabi’s VentureOne: Perceptra, a new cutting-edge GPS-less navigation technology, and Saluki, a high-security flight control technology for autonomous systems.

These technologies, both developed by the Technology Innovation Institute, are designed to deliver secure, resilient operations in the most challenging environments. They have been optimized for UAV manufacturers, offering enhanced resilience, precision, and security for autonomous aerial operations. The agreement between VentureOne, ADASI, and TII was formalized at IDEX 2025, t ... Read more »

ZUG, Switzerland 
These are the first approvals of nemolizumab from countries within the Access Consortium framework, with regulatory review processes ongoing in the remaining countries – Australia and Singapore
Nemolizumab, which is also approved in the EU and U.S., is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31 – a neuroimmune cytokine that drives itch and other symptoms in both moderate-to-severe atopic dermatitis and prurigo nodularis1-6
 

(BUSINESS WIRE)--Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of both atopic dermatitis and prurigo nodularis in the UK and Switzerland, respectively. Specifically, the approvals are for nemolizumab’s subcutaneous use for the treatment of moderate-to-severe atopic der ... Read more »

BURLINGAME, Calif. 
G2 Risk Solutions aims to bolster its footprint in Europe by acquiring ZignSec AB.
(BUSINESS WIRE)--G2 Risk Solutions (G2RS), a leading provider of risk management solutions in the financial sector, is announcing the acquisition of one of its affiliated companies of ZignSec AB (ZignSec). This marks a significant step forward in G2RS’ mission to deliver comprehensive, technology-driven compliance and risk solutions to regulated businesses worldwide.

ZignSec AB provides cutting-edge identity verification solutions and owns Web Shield, a leader in merchant due diligence services, and Wyzer, a business process optimization and automation specialist. The collaboration among the three companies is expected to enable G2RS to enhance its portfolio of services and broaden its reach into critical areas of risk and compliance management globally.

With this move, G2RS aims to strengthen its ability to serve highly regulated sectors, inc ... Read more »

ARLINGTON, Va. - Tuesday, 18. February 2025

(BUSINESS WIRE)--Today, Venture Global announced that it has notified its long-term customers that its Calcasieu Pass facility will commence commercial operations on April 15, 2025. The facility will achieve its commercial operation date, or COD, in under 68 months from its August 2019 final investment decision, despite substantial impacts including two hurricanes, the COVID-19 pandemic, and major unforeseen manufacturing issues, such as with the Heat Recovery Steam Generators (HRSGs) forming part of the facility’s power island.

Venture Global wishes to express its gratitude to its construction and completion teams who tirelessly worked to safely complete our facilities, to our vendor teams who provided invaluable support for the necessary repairs, and to our government regulators, including the Federal Energy Regulatory Commission, for their oversight and cooperation. These efforts now allow us to supply our long-ter ... Read more »

MOORESTOWN, N.J. - Tuesday, 18. February 2025

(BUSINESS WIRE)--OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, is introducing significant enhancements to its Infinity® Automated Storage and Retrieval System (AS/RS). Enhanced features include a 15 percent increase in the system’s storage payload, along with new storage slotting capabilities.

The Infinity AS/RS, launched in 2022, combines unparalleled storage density, configurability and flexibility to meet the most pressing warehouse automation challenges in micro-fulfillment, omni-channel distribution, store replenishment and ecommerce. While the Infinity system was previously capable of supporting 70-pound (31.7 kilogram) payloads, the enhanced system can support 90-pound (40.8 kilogram) payloads. In addition to Infinity iBOT robots now supporting the increased payload, the racking structure, also known as the ... Read more »

Prices for the ultra-luxury, record-setting skyscraper start at AED 10,000 per square foot
Burj Azizi offers the only freehold residences on all of Dubai’s Sheikh Zayed Road
The grand launch event will be held at Coca Cola Arena on the 18th of February 2025
 

Azizi Developments, a leading private developer in the UAE, will officially launch the sales of Burj Azizi, the world’s second-tallest tower, standing at an impressive 725 meters tall on a prime plot of land on Dubai’s Sheikh Zayed Road.

The grand launch event will be held at the Coca Cola Arena, City Walk on February 18th, featuring a headline performance by American singer Jennifer Lopez (JLo) and will welcome over 15,000 attendees. Among the guests are government officials, media representatives, brokerage partners, banks and financial institutions, investors, high-profile influencers and various celebrities.

Scheduled for completion by 2028, the 131+ story tow ... Read more »

MILPITAS, Calif. - Tuesday, 18. February 2025 AETOSWire 

Paolini to Wear Amazfit Smart Wearables to Enhance Performance and Recovery.

Amazfit logo to appear on Paolini’s on-court apparel.

(BUSINESS WIRE)--Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete partner. As part of the multi-year agreement and official smart wearable partnership, Paolini will represent Amazfit by wearing the Amazfit logo and smartwatch on court and the brand’s fitness wearables, including Helio Ring, to track sleep and athletic recovery.

Paolini is the current Italian No. 1 and highest-ranked Italian singles player in WTA history. She reached both singles and doubles finals at the 2024 French Open and was a singles finalist at 2024 Wimbledon. Additionally, Paolini is the reigning Olympic go ... Read more »

EXTON, Pa. - Monday, 17. February 2025 AETOSWire Print 

Winners to be Announced at the 2025 Year in Infrastructure Conference, Taking Place in Amsterdam on October 14-15

(BUSINESS WIRE)--Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced nominations are now open for the 2025 Going Digital Awards. This renowned global program recognizes the very best digital advancements in infrastructure delivery and performance. Independent jurors—consisting of thought leaders and experts in their field—select the winners from among the world’s most extraordinary infrastructure projects. The deadline for nominations is March 31, 2025.

Celebrating over 20 years, the awards program has recognized more than 5,250 of the world's most outstanding infrastructure projects. This global program is open ... Read more »

(BUSINESS WIRE)--Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in AOP Health’s favor. At the heart of the case were reciprocal claims for damages arising from a dispute regarding a licensing agreement between the parties.

The product in dispute

The conflict centers around ropeginterferon alfa-2b, a substance launched in 2019 and that AOP Health has developed into an innovative treatment (BESREMi®) for rare blood cancers, particularly polycythemia vera, through a comprehensive clinical trial program. This makes BESREMi® the best investigated interferon in clinical trials in this indication as documented in the major relevant guidelines1. AOP Health had acquired the rights for both BESREMi®’s development and commercialization in th ... Read more »